Effects of open-label placebos on overweight adults

Effects of open-label placebos on overweight adults - PLEAT2

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00033046

Enrollment

Registered

2023-11-15

Start date

2023-11-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight

Interventions

Group 1: Intervention group receives placebos (2 each day) for 4 weeks Group 2: Control group (no placebo)

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Overweight (BMI > 25)

Exclusion criteria

Exclusion criteria: known psychiatric or neurological diseases; eating disorders; pregnancy

Design outcomes

Primary

Measure	Time frame
BMI index at baseline and after 4 weeks	—

Secondary

Measure	Time frame
Eating behavior (FEV-questionnaire) at baseline and after 4 weeks	—

Countries

Germany

Contacts

Public ContactMichael Schaefer

Medical School Berlin

michael.schaefer@medicalschool-berlin.de+49 (0) 306117542

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026